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Identifying genetic locations of genes for complex traits
such as psoriasis is a challenge. The approach that has
been used is to identify large numbers of families with two
or more affected children, and to perform a genome-wide
linkage scan. The results of such studies are statistical es-
timates that a DNA marker is segregating with psoriasis in
families more often than expected due to chance. In most
linkage scans for genes for complex traits, the convention-
ally accepted statistical threshold, a logarithm of the odds
(LOD) score of 3, is rarely met, and large numbers of po-
tentially linked loci lie below this threshold. The hope is that
additional scans with additional families will pinpoint the
same regions. Such replication would be further evidence
that one has localized a psoriasis locus.
In the past 10 years, 10 genome-wide linkage scans for
psoriasis susceptibility loci have been conducted. This has
led to the identification of 19 potentially susceptible loci on
15 different chromosomes. The only locus consistently
identified is that harboring the associated HLA class I region
(PSORS1). Evidence for linkage to other regions is consist-
ently lower, presumably because the effects conferred by
these regions are less than that conferred by PSORS1. As a
result, some of these linkages may be spurious. Moreover,
since effects are weak, evidence for linkage to bonafide
psoriasis loci is not provided by all scans. There is also the
possibility that some susceptibility loci are found in only
some psoriasis populations. Given that effects of non-HLA
loci are weak, it is also possible that real loci with weak
effects are not reported.
The weak effects of susceptibility regions are in part due
to the fact that the diseases in question are polygenic; the
presence of disease requires the presence of additional
susceptibility alleles. These alleles may be common in the
population. There may also be a requirement for an envi-
ronmental trigger. Moreover, it is not clear if the genetic risk
factors leading to psoriasis are the same in all individuals.
For example, it is possible that there is a threshold of im-
mune system activation that needs to be overcome before
the disease manifests itself. This level of activation could be
reached if one harbors a number of different genetic var-
iants or combinations of variants.
When attempting to localize genes for complex traits a
meta-analysis can be useful. This has been defined as ‘‘The
analysis of analyses––the statistical analysis of a large col-
lection of analysis results from individual studies for the
purpose of integrating the findings’’ (Glass, 1976). One of
the advantages of such an approach is that it can identify
secondary linkage peaks that are borderline in one scan,
but that are consistently observed in all or many other
scans. These would be indicative of a psoriasis locus of
weak effect. For genetic linkage studies, a meta-analysis
could integrate marker data and combine LOD scores or
p-values across studies to obtain a consensus.
Meta-analyses have their own problems, some of which
are associated with heterogeneity among studies. These
include variability in criteria for diagnoses, sample sizes,
environmental factors, ascertainment schemes, markers,
and marker density.
Sagoo et al (2004) conducted a meta-analysis of six
previous linkage scans for psoriasis susceptibility loci. Five
of these were conducted on large numbers of families of
Northern European origin. The sixth scan was conducted
with families from the Chinese Han population. Since dif-
ferent markers had been used in the six studies the authors
used a binning approach (initially described by Wise et al,
1999) to compare linkage peaks obtained from the different
studies. The genome was divided into 110 distinct regions–
–or ‘‘bins’’––each spanning 33 cM, and evidence for link-
age with each bin was evaluated across all studies. After
adjusting for multiple tests, only two regions remained
significant. The strongest evidence for linkage was not
unexpectedly obtained with markers from the MHC region.
The second strongest peak, however, was obtained with
markers from a region on chromosome 4q28–q31. This was
not a region of compelling linkage that had been reported
following five of the scans. It had been detected previously
in a linkage scan for psoriasis susceptibility loci using fam-
ilies from the Chinese Han population (Zhang et al, 2002)
and given the name PSORS9.
This observation is interesting for two reasons. First,
meta-analysis identified a linkage peak that had not been
highlighted consistently in other linkage scans. Second, this
locus was identified in families of both Northern European
and Asian origin. This suggests that the susceptibility var-
iant arose before the divergence of these two populations
(  70,000 years ago) (Bowcock et al, 1994). An alternative
explanation is that the variant has arisen independently in
the two populations.
Chromosome 4q has been of interest since a scan of
seven Irish families with psoriasis revealed evidence for
linkage to the end of this chromosomal arm (Matthews et al,
1996). In this case the peak LOD score was slightly distal to
the linkage peak identified from meta-analyses (4q35.1).
This locus had been termed PSORS3. Other linkage scans
have identified a slightly more proximal region of chromo-
some 4q as harboring a psoriasis susceptibility locus (Bhal-
erao and Bowcock, 1998; Samuelsson et al, 1999).
These findings prompt the question: Does the 4q28–q31
linkage finding correspond to a single locus for psoriasis
susceptibility, or does 4q harbor a number of psoriasis
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susceptibility loci? Clustering of genes for complex traits is
not unusual. For example, 17q25 also harbors at least two
psoriasis susceptibility loci (Helms et al, 2003); there is a
cluster of genes for murine systemic lupus erythematosus
(SLE) on chromosome 1q (Morel et al, 2001) and there are
likely to be two Crohn’s disease loci within  20 cM on
chromosome 16q (Adeniji et al, 2002). Such clustering of
genes for complex traits may facilitate the identification of
susceptibility loci since it increases the likelihood of at least
one locus being detected in a genome-wide linkage scan. It,
however, makes the precise localization of the genes harder
to determine.
Figure 1 indicates the locations of particularly compelling
candidate genes lying within the 4q28–q35 interval. They
include interleukin-15 (IL-15), a cytokine that triggers in-
flammatory cell recruitment, angiogenesis, and production
of other inflammatory cytokines, some of which are upreg-
ulated in psoriatic lesions including interferon-g (IFN-g),
tumor necrosis-a (TNF-a), and interleukin-17 (IL-17). More-
over, in a human psoriasis xenograft model, an IL-15-spe-
cific antibody reduced the severity of psoriasis, as
measured by epidermal thickness, grade of parakeratosis,
and numbers of inflammatory cells and cycling keratin-
ocytes (Villadsen et al, 2003). This region also harbors LPS-
responsive vesicle trafficking, beach and anchor containing
gene (LRBA), a gene mutated in patients with the immuno-
deficiency syndrome, Chediak–Higashi (CHS1) (Barbosa et
al, 1996); toll-like receptor genes 2 and 3 (TLR2 and TLR3)
that play a fundamental role in pathogen recognition and
activation of innate immunity and whose expression is en-
hanced by IFN-g in macrophages, and in epithelial and
endothelial cells, respectively (Cario and Podolsky, 2000);
vascular endothelial growth factor C (VEGFC), the paracrine
factor required for normal lymphatic development (Karkkai-
nen et al, 2004) and interferon regulatory factor 2 (IRF2).
IRF2 is involved in negative regulation of IFN-g signaling and
has already been proposed as a susceptibility gene for
psoriasis (PSORS3) (Foerster et al, 2004). It should, how-
ever, be noted that at least 300 genes lie within this interval,
so that the above represent a handful that could be involved
in psoriasis susceptibility and there are undoubtedly addi-
tional compelling candidates. Association studies across
this interval may ultimately identify the causative gene(s)
and associated variant(s).
This study illustrates the power of meta-analyses, partic-
ularly for complex traits such as psoriasis. It should, how-
ever, be noted that these analyses do not preclude the
existence of some of the other loci identified in previous
linkage scans. Nevertheless, it has highlighted an important
locus for psoriasis susceptibility at chromosome 4q28–q31
that should be the target of future gene identification studies.
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Figure 1
Candidate psoriasis genes on chromosome 4q28–q35; a region
identified as harboring psoriasis susceptibility loci from some
genome-wide linkage scans and a meta-analysis.
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